Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Coronary Hybrid Revascularisation Study Registry on Treatment of Significant Coronary Artery Disease by Combined Bypass Operation (CABG) and Catheter Based Treatment (PCI)

NCT01496664 is registered in ClinicalTrials.gov with Aarhus University Hospital Skejby as lead sponsor.

NCT NCT01496664
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01496664 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Coronary Hybrid Revascularisation Study Registry on Treatment of Significant Coronary Artery Disease by Combined Bypass Operation (CABG) and Catheter Based Treatment (PCI)
Lead sponsor
Aarhus University Hospital Skejby
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2010
Completion date
December 31, 2022
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

significant coronary artery disease